Home/Filings/4/0001209191-19-016413
4//SEC Filing

HATFIELD DAVID P 4

Accession 0001209191-19-016413

CIK 0001096752other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 4:10 PM ET

Size

27.1 KB

Accession

0001209191-19-016413

Insider Transaction Report

Form 4
Period: 2019-03-01
HATFIELD DAVID P
EXECUTIVE VP, CMO
Transactions
  • Other

    Non-Qualified Stock Options 11/3/2016

    2019-03-013,71112,989 total
    Exercise: $74.70Common Stock (3,711 underlying)
  • Other

    Restricted Stock Equivalent 11/13/2017

    2019-03-014,9816,225 total
    Exercise: $0.00Common Stock (4,981 underlying)
  • Other

    Performance Stock Equivalents 11/13/2017

    2019-03-0131,12724,901 total
    Exercise: $0.00Common Stock (31,127 underlying)
  • Exercise/Conversion

    Common Stock

    2019-03-01+52,238104,615 total(indirect: By Trust)
  • Other

    Restricted Stock Equivalent 11/3/2016

    2019-03-019923,470 total
    Exercise: $0.00Common Stock (992 underlying)
  • Other

    Non-Qualified Stock Options 11/13/2017

    2019-03-0112,00515,005 total
    Exercise: $58.90Common Stock (12,005 underlying)
  • Other

    Restricted Stock Equivalents 11/15/2018

    2019-03-0123,1800 total
    Exercise: $0.00Common Stock (23,180 underlying)
  • Other

    Performance Stock Equivalents 11/3/2016

    2019-03-014,46215,619 total
    Exercise: $0.00Common Stock (4,462 underlying)
  • Other

    Non-Qualified Stock Options 11/15/2018

    2019-03-0150,8870 total
    Exercise: $42.71Common Stock (50,887 underlying)
  • Other

    Performance Stock Equivalents 11/15/2018

    2019-03-01241,1620 total
    Exercise: $0.00Common Stock (241,162 underlying)
Holdings
  • Common Stock

    18,619
Footnotes (6)
  • [F1]Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hatfield's departure from the Company on March 1, 2019. These shares of Edgewell common stock will be delivered to Mr. Hatfield on September 3, 2019.
  • [F2]Unvested award forfeited upon Mr. Hatfield's departure from the Company on March 1, 2019.
  • [F3]These shares vested upon Mr. Hatfield's departure from the Company on March 1, 2019. These shares will be delivered to Mr. Hatfield on September 3, 2019.
  • [F4]These options vested upon Mr. Hatfield's departure from the Company. He will have 5 years from his departure date to exercise them.
  • [F5]These PSEs will vest and convert into shares of Edgewell common stock upon the release of earnings for fiscal year ending September 30, 2019 if specified performance criteria are met subject to the exercise of negative discretion by the Compensation Committee of Edgewell's Board of Directors. The performance goal for the PSEs is the adjusted earnings per share of the Company for its 2019 fiscal year.
  • [F6]These PSEs will vest and convert into shares of Edgewell common stock upon the release of earnings for fiscal year ending September 30, 2020 if specified performance criteria are met subject to the exercise of negative discretion by the Compensation Committee of Edgewell's Board of Directors. The performance goal for the PSEs are the adjusted earnings per share of the Company for its 2020 fiscal year and the adjusted cumulative free cash flow of the Company for its 2020 fiscal year as a percentage of adjusted net sales of the Company for its 2020 fiscal year.

Issuer

EDGEWELL PERSONAL CARE Co

CIK 0001096752

Entity typeother

Related Parties

1
  • filerCIK 0001283856

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:10 PM ET
Size
27.1 KB